These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1492140)

  • 1. Depressive attributional style and the dexamethasone suppression test: relationship to the endogenous/melancholic distinction and to each other.
    Peselow ED; Fieve RR
    Psychopathology; 1992; 25(4):173-82. PubMed ID: 1492140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of four definitions of melancholia by the dexamethasone suppression test.
    Davidson J; Lipper S; Zung WW; Strickland R; Krishnan R; Mahorney S
    Am J Psychiatry; 1984 Oct; 141(10):1220-3. PubMed ID: 6486256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melancholic/endogenous depression and response to somatic treatment and placebo.
    Peselow ED; Sanfilipo MP; Difiglia C; Fieve RR
    Am J Psychiatry; 1992 Oct; 149(10):1324-34. PubMed ID: 1388334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF; Hunt G; Kerr K; Caterson I
    Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
    Kumar A; Alcser K; Grunhaus L; Greden JF
    Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria.
    Carroll BJ; Feinberg M; Greden JF; Haskett RF; James NM; Steiner M; Tarika J
    J Affect Disord; 1980 Sep; 2(3):177-94. PubMed ID: 6210723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone suppression test and REM sleep in patients with major depressive disorder.
    Mendlewicz J; Kerkhofs M; Hoffmann G; Linkowski P
    Br J Psychiatry; 1984 Oct; 145():383-8. PubMed ID: 6487911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone suppression test and treatment response.
    Gitlin MJ; Gwirtsman H; Fairbanks L; Sternbach HA; Cedars PI; Gerner RH
    J Clin Psychiatry; 1984 Sep; 45(9):387-9. PubMed ID: 6469923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. A test unaffected by the variations in the bioavailability of dexamethasone.
    Maes M; Vandewoude M; Schotte C; Cosyns P
    Neuropsychobiology; 1989; 22(1):26-32. PubMed ID: 2639285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DSM-III melancholia: do the criteria accurately and reliably distinguish endogenous pattern depression?
    Copolov DL; Rubin RT; Mander AJ; Sashidharan SP; Whitehouse AM; Blackburn IM; Freeman CP; Blackwood DH
    J Affect Disord; 1986; 10(3):191-202. PubMed ID: 2943772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopathological correlates of plasma cortisol after dexamethasone suppression: a polydiagnostic approach.
    Philipp M; Maier W; Holsboer F
    Psychoneuroendocrinology; 1986; 11(4):499-507. PubMed ID: 3562743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder.
    Insel TR; Kalin NH; Guttmacher LB; Cohen RM; Murphy DL
    Psychiatry Res; 1982 Apr; 6(2):153-60. PubMed ID: 6953457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: a confirmatory report.
    Cottraux JA; Bouvard M; Claustrat B; Juenet C
    Psychiatry Res; 1984 Oct; 13(2):157-65. PubMed ID: 6596583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The research diagnostic criteria for endogenous depression and the dexamethasone suppression test: a discriminant function analysis.
    Zimmerman M; Stangl D; Coryell W
    Psychiatry Res; 1985 Mar; 14(3):197-208. PubMed ID: 3858892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An evaluation of some of the relationships between thought-action fusion, attributional styles, and depressive and obsessive-compulsive symptoms].
    Piri S; Kabakçi E
    Turk Psikiyatri Derg; 2007; 18(3):197-206. PubMed ID: 17853974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenocortical function in geriatric depression: diagnostic and treatment implications.
    Georgotas A; Stokes PE; Krakowski M; Fanelli C; Cooper T
    Biol Psychiatry; 1984 May; 19(5):685-93. PubMed ID: 6733180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of attributional style to agoraphobia severity, depression, and treatment outcome.
    Michelson LK; Bellanti CJ; Testa SM; Marchione N
    Behav Res Ther; 1997 Dec; 35(12):1061-73. PubMed ID: 9465440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test in a group of research diagnostic criteria schizoaffective depressed men.
    Wahby VS; Ibrahim GA; Giller EL; Saddik FW; Mason JW; Adams JR
    Neuropsychobiology; 1990-1991; 23(3):129-33. PubMed ID: 2098669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression test in hospitalized depressed patients with borderline personality disorder.
    Beeber AR; Kline MD; Pies RW; Manring JM
    J Nerv Ment Dis; 1984 May; 172(5):301-3. PubMed ID: 6716096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.